Physician
Michael Scott Mcallister, M.D.
According to 2025 Medicare claims, Michael Mcallister, M.D. (NPI: 1720170053) practices hematology/oncology in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is DOTHAN HEMATOLOGY & ONCOLOGY PC (NPI: 1942393913; TIN: 63-1012171) and primary practice location at 36303-2031.
Mcallister's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 878 traditional Medicare patients, billed 254,954 HCPCS/CPT codes, and received $4,415,674 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,799 prescription claims across 339 beneficiaries totaling $6,628,230 in drug costs, led by Xtandi (Enzalutamide). DME data shows 204 claims. Open Payments data shows 139 records totaling $50,899. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,780,617 to $4,415,674. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,689,097 to $6,628,230. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,712 to $15,493.